Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00774605 · ClinicalTrials.gov registry record · Phase 1
A Study Evaluating The Absorption Of Varenicline Into The Body From A Varenicline Solution And A Varenicline Patch Applied To The Skin
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00774605 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 12 participants.
The verdict
NCT00774605, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
To evaluate the absorption, safety, and tolerability of a varenicline solution and a varenicline patch applied to the skin.
Interventions
- DRUG Varenicline free base solution
- DRUG Varenicline free base patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2008-12 |
| Est. Completion | 2008-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00774605
The ClinicalTrials.gov registry entry for NCT00774605 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Varenicline free base solution is the first listed.
NCT00774605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00774605 about?
NCT00774605 is a clinical study titled "A Study Evaluating The Absorption Of Varenicline Into The Body From A Varenicline Solution And A Varenicline Patch Applied To The Skin". To evaluate the absorption, safety, and tolerability of a varenicline solution and a varenicline patch applied to the skin.
What is the current status of trial NCT00774605?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2008-12. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00774605?
The interventions under investigation include: Varenicline free base solution (DRUG), Varenicline free base patch (DRUG).
Who is sponsoring clinical trial NCT00774605?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.